Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sunrest LifescienceNSE:SUNREST 42 Days Inventory is 104.03 as of Mar. 2026, which is 36% above its 10-year median of 76.50. GuruFocus rates NSE:SUNREST with a GF Score™ of 42/100. The stock has 5 warning signs investors should review. Among 497 Healthcare Providers & Services companies, Sunrest Lifescience ranks worse than 93.96% on this metric.
The historical rank and industry rank for Sunrest Lifescience's Days Inventory or its related term are showing as below:
NSE:SUNREST'
s Days Inventory Range Over the Past 10 Years
Min: 23.49 Med: 76.5 Max: 208.05
Current: 208.05
During the past 7 years, Sunrest Lifescience's highest Days Inventory was 208.05. The lowest was 23.49. And the median was 76.50.
NSE:SUNREST's Days Inventory is ranked worse than 93.96% of 497
companies
in the Healthcare Providers & Services industry
Industry Median: 29.67
vs NSE:SUNREST: 208.05
Sunrest Lifescience's Days Inventory
declined
from Sep. 2024 (123.42) to Mar. 2026 (104.03).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Sunrest Lifescience's Inventory Turnover for the
six
months ended in Mar. 2026 was 1.75.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sunrest Lifescience's Inventory-to-Revenue for the
six
months ended in Mar. 2026 was 0.36.
Sunrest Lifescience (NSE:SUNREST) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Sunrest Lifescience's Inventory Turnover for the
six
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sunrest Lifescience's Inventory to Revenue for the
six
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Sunrest Lifescience Days Inventory Related Terms
Sunrest Lifescience Days Inventory Historical Data
* Premium members only.
The historical data trend for Sunrest Lifescience's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sunrest Lifescience Days Inventory Competitor Comparison
For the Pharmaceutical Retailers subindustry, Sunrest Lifescience's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sunrest Lifescience Days Inventory vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sunrest Lifescience's Days Inventory distribution charts can be found below:
* The bar in red indicates where Sunrest Lifescience's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sunrest Lifescience (NSE:SUNREST) has a Days Inventory of 104.03 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sunrest Lifescience and its competitors. This is 36% above median its historical median of 76.50. Over the past decade, Sunrest Lifescience's Days Inventory has ranged from 23.49 to 208.05. According to the industry distribution chart, Sunrest Lifescience ranks #467 out of 497 companies in the Healthcare Providers & Services industry, placing it in the top 94%.
Is Sunrest Lifescience's Days Inventory too high?
Sunrest Lifescience's current Days Inventory of 104.03 is 36% above median its 10-year median of 76.50. Over the past 10 years, this metric has ranged from a low of 23.49 to a high of 208.05. The Healthcare Providers & Services industry median Days Inventory is 29.67. Sunrest Lifescience's value of 104.03 is 250.6% above this industry median. Based on the distribution chart, Sunrest Lifescience ranks #467 out of 497 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Sunrest Lifescience has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Sunrest Lifescience's Days Inventory compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Sunrest Lifescience ranks #467 out of 497 companies for Days Inventory. This places Sunrest Lifescience in the lower half of its industry. The industry median Days Inventory is 29.67. Sunrest Lifescience's value of 104.03 is 250.6% above this benchmark. Historically, Sunrest Lifescience's own Days Inventory has ranged from 23.49 to 208.05 over the past decade. While the company's 10-year median is 76.50 vs. the industry median of 29.67, Sunrest Lifescience has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Healthcare Providers & Services company?
The median Days Inventory among Healthcare Providers & Services companies is 29.67, based on 497 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sunrest Lifescience's current Days Inventory of 104.03 is 250.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sunrest Lifescience and its competitors. For the Healthcare Providers & Services industry, the median Days Inventory is 29.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunrest Lifescience's current Days Inventory is 104.03, which is 36% above median its own 10-year median of 76.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunrest Lifescience stock overvalued right now?
Sunrest Lifescience (NSE:SUNREST) has a current Days Inventory of 104.03. The current Days Inventory is 104.03, which is 36% above median its 10-year median of 76.50 and 250.6% above the Healthcare Providers & Services industry median of 29.67. Sunrest Lifescience's overall GF Score™ is 42/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Sunrest Lifescience (NSE:SUNREST), the current Days Inventory is 104.03 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sunrest Lifescience Ltd is engaged in the trading business of pharmaceutical products, including capsules, tablets, syrups, ointments, gels, mouthwash, and toothpaste on a wholesale and retail basis. Its product portfolio covers categories such as anti-bacterial, anti-diarrheal, anti-fungal, anti-malarial, anti-diabetic, dental care, anti-inflammatory, nutraceuticals, and more. The company works with a network of suppliers and super suppliers, distributing products to chemists, hospitals, and dispensaries across multiple Indian states. Sunrest relies on both in-house manufacturing through its group company Trilend Pharmaceuticals and third-party manufacturers, emphasizing quality control and regulatory compliance.
42GF Score
Get the complete analysis for NSE:SUNREST
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SUNREST has been successfully added to your 
